Aktie CANQF CANAQUEST MEDICAL CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen CanaQuest Medical Corp. Other OTC

Aktien

CANQF

CA1372201097

CANQF

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials
CanaQuest Medical Corp. Announces Appointment of Dr. Paul Dick, Chairman of Advisory Board
NHL Alumni Association Partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in Former NHL Players
CanaQuest Medical Corp. cancelled the transaction announced on October 26, 2022
CANAQUEST Announces Award of European Cannabinoid Patent
CanaQuest Medical Corp. Announces Award of European Cannabinoid Patent
CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health and Pharma for their 8th Annual Healthcare and Pharmaceutical Program
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD
CanaQuest Medical Corp. announced a financing transaction
CanaQuest Medical Corp. Launches Mentanine (R) (Cannabidiol + IP Formula) in the US
CanaQuest Medical : Interim Consolidated Consolidated Financial Statements (unaudited) - June 30, 2022
CanaQuest Medical : Attorney Letter
CanaQuest Medical : Financial Statements (unaudited) - March 31, 2022
CanaQuest Medical Corp. Appoints Rob Rinderman as New Director of Communications
Canaquest Signs Medicinal Cannabis Education Partnership with the Canadian Cannabis Dispute Resolution Centre
CANAQUEST MEDICAL CORP Announces New Production and Distribution Agreement with PurCann Pharma and SiliCycle Inc
CANAQUEST MEDICAL CORP SECURES APPROVAL FOR LISTING ON THE OCMX™, AN ONLINE INVESTOR AND FINANCIAL CONNECTION PORTAL
UPDATE: CANAQUEST MEDICAL CORP FILES PROVISIONAL PATENT FOR MENTANINE® - OMEGA-3 & PURE CANNABIDIOL (“CBD”) FORMULATION BOOSTING MENTAL HEALTH EFFICACY WHILE MINIMIZING CBD DOSAGE
CANAQUEST MEDICAL CORP FILES PROVISIONAL PATENT FOR MENTANINE® - OMEGA-3 & PURE CANNABIDIOL (“CBD”) FORMULATION BOOSTING MENTAL HEALTH EFFICACY WHILE MINIMIZING CBD DOSAGE
CanaQuest Medical Corp. Files A Provisional Cannabidiol/Omega-3 Patent, Trade Named Mentanine®
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. CANQF Aktie
  4. CANQF Aktie
  5. Nachrichten CanaQuest Medical Corp.
  6. Andere Sprachen